Registered entities
AKERO THERAPEUTICS, INC.
Reg. No. 815266573United States
Innovation
4 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 99 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Social engagement
Social engagement: 14.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Janus Henderson Investors, Apple Tree Partners, Atlas Venture; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Private equity | 3 | 21% |
| Other / undisclosed | 3 | 21% |
Hiring activity
Hires occasionally
7 roles tracked across 1 of the last 12 months
8 Nov 2025 · Manager of Quality Assurance · Murrieta
7 Nov 2025 · Senior Manager, Regulatory Affairs · Denver
7 Nov 2025 · Contracts Specialist · Fresno
Based on job postings tracked across public sources.
Recent activity
26 Jun 2026
Event
SOLAR Conference 2026
18 May 2026
Event
American Diabetes Association (ADA) 2026 Scientific Sessions
14 May 2026
Event
2026 EASL | The Home of Hepatology Congress